Back to News
Market Impact: 0.7

Cannabis stocks and marijuana rescheduling hopes high after Donald Trump social media post

DJTCGCTLRYCRONACBMSOS
Elections & Domestic PoliticsRegulation & LegislationHealthcare & BiotechCompany FundamentalsMarket Technicals & FlowsInvestor Sentiment & Positioning
Cannabis stocks and marijuana rescheduling hopes high after Donald Trump social media post

Cannabis stocks, including Canopy Growth and Tilray, surged by up to 20% and the AdvisorShares Pure U.S. Cannabis ETF climbed 25.2% after President Trump posted a video on Truth Social promoting medical cannabis and CBD for senior healthcare. This action fueled speculation among investors and industry insiders that federal marijuana rescheduling, which has been in limbo despite previous reviews, may be imminent, signaling a potential shift in policy for the $32 billion industry.

Analysis

Cannabis equities experienced a significant catalyst-driven rally following a social media post by President Donald Trump that highlighted the potential medical benefits of cannabidiol (CBD). The market reaction was immediate and pronounced, with U.S.-listed shares of Canopy Growth and Tilray Brands surging nearly 20%, while the AdvisorShares Pure U.S. Cannabis ETF (MSOS) jumped 25.2%. This price action is rooted in renewed speculation that the administration is preparing to reschedule marijuana under federal law, a move that the industry has long awaited. The video shared by the president, produced by a medical marijuana advocacy group, specifically frames cannabis reform as a major healthcare initiative for seniors with a potential $64 billion in savings, directly appealing to the president to act. This event gains significance in the context of a stalled federal review process; a Department of Health and Human Services recommendation to reclassify cannabis in August 2023 has yet to result in a final decision from the Justice Department. While industry executives interpret the post as a strong signal of an impending policy decision, it is crucial to note that this momentum is based on a political signal rather than a concrete regulatory change, and Trump had previously hinted at a decision in August that did not materialize.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.